Type of MS: PPMS
Treatment mode of action: To increase time to progression
Number of Subjects: 2
Medication: ocrelizumab
Location: California
Institutions: UC Davis Medical Center- Department of Neurology\
Sacramento, CA
Contact Information
Alaina Friesen
916-734-6231
amfriesen@ucdavis.edu